IN THIS EPISODE - What a peptide actually is, and why your GLP-1 is NOT the same thing as BPC-157 or TB-500 - The seven peptides the FDA is reviewing: BPC-157, KPV, TB-500 (the "Wolverine complex"), MOTS-c, DSIP, Semax, and Epitalon - The "funding gap" why peptides that can't be patented never get human clinical trials - Six things the FDA worries about in an unlabeled vial, from identity and purity to the cancer/angiogenesis risk - The two questions that tell you if a peptide provider is legitimate (503A/B pharmacies and third-party certificates of analysis) ABOUT THE GUEST Tanna Donalson is a Physician Assistant and Owner of Redbud Medical in Denver Colorado
Low protein intake can become a concern when appetite drops
Collagen gip da n hi, mn mng, h tr Glutathione duy tr cng sng lu di
for a minority, short-term changes in hydration, blood sugar, or hormonal signaling reveal arrhythmias or palpitations that need attention
Compounding pharmacies often provide semaglutide in different concentrations, requiring conversion calculations
